BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1297 related articles for article (PubMed ID: 22257424)

  • 21. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
    Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
    Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: Comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype.
    Liu N; Huang D; Cheng X; Chong Y; Wang W; Gan W; Guo H
    Urol Oncol; 2017 Aug; 35(8):530.e1-530.e6. PubMed ID: 28408296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma.
    Andrade HS; Zargar H; Caputo PA; Akca O; Kara O; Ramirez D; Haber GP; Stein RJ; Kaouk JH
    Eur Urol; 2016 Jun; 69(6):1149-54. PubMed ID: 26719014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thermal ablation of small renal masses: intermediate outcomes from a Canadian center.
    Erdeljan P; Dhar M; Wignall G; Kozak R; Pautler SE
    Can J Urol; 2011 Oct; 18(5):5903-7. PubMed ID: 22018153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microwave ablation versus partial nephrectomy for small renal tumors: intermediate-term results.
    Guan W; Bai J; Liu J; Wang S; Zhuang Q; Ye Z; Hu Z
    J Surg Oncol; 2012 Sep; 106(3):316-21. PubMed ID: 22488716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma.
    Bertini R; Roscigno M; Freschi M; Strada E; Angiolilli D; Petralia G; Matloob R; Sozzi F; Capitanio U; Da Pozzo LF; Colombo R; Guazzoni G; Cremonini A; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):358-65. PubMed ID: 21640483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable.
    Shindo T; Masumori N; Kobayashi K; Fukuta F; Hirobe M; Tonooka A; Hasegawa T; Kitamura H; Tsukamoto T
    BJU Int; 2013 May; 111(6):941-5. PubMed ID: 23350965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
    J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
    Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive factors for late recurrence in patients with stage T1 clear cell renal cell carcinoma: a multiinstitutional study.
    Ha YS; Park YH; Kang SH; Hong SH; Hwang TK; Byun SS; Kim YJ
    Clin Genitourin Cancer; 2013 Mar; 11(1):51-5. PubMed ID: 23017336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
    Blute ML; Amling CL; Bryant SC; Zincke H
    Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
    Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA
    J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.
    Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB
    J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
    Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
    Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results.
    Beemster PW; Barwari K; Mamoulakis C; Wijkstra H; de la Rosette JJ; Laguna MP
    BJU Int; 2011 Aug; 108(4):577-82. PubMed ID: 21044249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
    Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
    BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
    Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG
    BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
    Daugherty M; Bratslavsky G
    Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.